PLANNING AND EVALUATION
PLANNING AND EVALUATION
批准号:
8436458
负责人:
William L. Carroll
金额:
$4.47万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2018-02-28
关键词:
AddressAdultAnalytical ChemistryAnimalsAreaAwardBioinformaticsBreastCancer CenterCancer Center Support GrantCancer ControlCancer Control Research ProgramCancer EtiologyCaringChildhood Acute Lymphocytic LeukemiaClinicalClinical Cancer CenterClinical ResearchClinical Research ProtocolsClinical ServicesClinical TrialsCollaborationsCommunitiesComplexCore FacilityDental SchoolsDevelopmentDiagnosticDiseaseDoctor of PhilosophyDropsEarly DiagnosisEconomicsEnvironmental MedicineEnvironmental Risk FactorEpidemiologic StudiesEpidemiologyEpigenetic ProcessEvaluationExperimental PathologyFacultyFundingGenomeGoalsGrantGrowthHawaiiHealthHealthcareHearingHematologic NeoplasmsHematologyHospitalsHousingHuman GeneticsHuman MicrobiomeInstitutesInvestmentsLaboratoriesLaboratory FindingLeadLeadershipLibrariesLungMalignant NeoplasmsMalignant neoplasm of ovaryMedical OncologyMedical centerMedicineMesotheliomaMetabolicMethodsMissionModificationMolecular ImmunologyNamesNew YorkNew York CityObesityOutcomeOutcomes ResearchOutreach ResearchPatientsPilot ProjectsPopulation SciencesPreventionProcessProteomicsProteomics Shared ResourcePublic HospitalsPublicationsRNA InterferenceRadiation OncologyRecommendationRecruitment ActivityReproductive HistoryResearchResearch InfrastructureResearch PersonnelResource SharingResourcesRisk FactorsScienceSeriesServicesSisterStrategic PlanningSurvivorsTechnologyTobacco useTrainingTransgenic Mouse FacilityTranslatingTranslational ResearchTranslationsUniversitiesUpdateVisionWorkanticancer researchbasebiobankbioimagingbiomedical informaticscancer epidemiologycancer riskclinical careclinical practiceclinical research sitedrug discoveryinformatics shared resourcelung cancer screeninglung melanomamalignant breast neoplasmmalignant mouth neoplasmmedical schoolsmeetingsmelanomamembermicrobiomemolecular oncologymultidisciplinarynew technologynext generation sequencingorganizational structurepopulation basedpre-clinicalprogramsresponsescreeningsocialtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PLANNING AND EVALUATION
The NYUCI has engaged in continuous strategic planning across the entire cancer enterprise at the NYU Langone Medical Center. Accomplishments include the new Epidemiology and Cancer Control Research Program that is the center of the Institute's population sciences research, and through partnership with David Levy, PhD, Assistant Dean for Collaborative Sciences, developed the Medical Center's initiative to invest $26m in the strategic expansion of and oversight of shared core facilities. Results from this partnership included a new Biomedical Informatics Shared Resource, an established RNAi Shared Resource, new technologies for the Genome Technology Center including next generation sequencing, a completely revised Proteomics Shared Resource, an enhanced Biorepository Center Shared Resource that is an outgrowth of the TABs facility previously hou.sed in the Experimental Pathology Shared Resource, and the complete redesign of the Core Clinical Laboratory, through a merger with a similar service of the CTSA, into a vibrant Translational Research Laboratory Shared Resource.
Through strategic efforts, the Cancer Institute invested heavily in clinical research infrastructure to support access to and accrual of patients to clinical research protocols at Bellevue Cancer Center that led to an almost 50% increase in accrual to clinical trials since the previous review. Organizationally, the Cancer Institute merged the Divisions of Hematology and Medical Oncology to create the Division of Hematology and Medical Oncology housed in the Institute and recruited the Division Chief. Owen O'Connor, MD, PhD was recruited and named the new Division Chief in 2010, yet returned to Columbia University this year. Recruitment for a new division chief is currently underway. NYUCI leadership developed this organizational structure to create full alignment of mission and vision, and the ability to effect change quickly to take full advantage of the unique academic, financial and community resources to meet the needs of our members and to achieve the overall goals of the Institute.
Senior Leadership recognizes the importance of transparency in planning initiatives, and supports several venues to involve membership in both the planning and evaluative process. Since the last review, the NYUCI held a senior leadership retreat and updated the original Strategic Plan in 2010, (approved in 1999 and amended in 2002, 2004, and 2008); chaired an internal shared resource evaluation July, 2011; re-evaluated membership criteria; expanded the External Advisory Board (EAB) membership to include expertise in epigenetics, radiation oncology, prevention and control, and cancer center leadership; brought in ad hoc consultants to advise on our population sciences initiatives; reviewed and evaluated research programs; cochaired the committee that planned and implemented the institutional investment and development of an Office of Collaborative Sciences to manage shared core facilities; and was instrumental in the institutional planning process to build a new community cancer center at the Woodhull Medical Center, in Brooklyn, a sister New York City public hospital of Bellevue Hospital. Funds over the past five years supported the EAB, planning meetings to develop scientific rigor and collaborations in population sciences, and to host the annual NYU Cancer Institute Translational Research Retreat.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
-
批准号:10381569
-
项目类别:
-
资助金额:$44.26万
-
财政年份:2021
-
负责人:William L. Carroll
-
依托单位:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
-
批准号:10184002
-
项目类别:
-
资助金额:$47.59万
-
财政年份:2021
-
负责人:William L. Carroll
-
依托单位:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
-
批准号:10631888
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2021
-
负责人:William L. Carroll
-
依托单位:
BIOMEDICAL INFORMATICS
-
批准号:8436451
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
PROTEOMICS
-
批准号:8436447
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:8436459
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
BIOSTATISTICS
-
批准号:8436452
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
EXPERIMENTAL PATHOLOGY
-
批准号:8436442
-
项目类别:
-
资助金额:$7.03万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
ADMINISTRATION
-
批准号:8436460
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
EPIDEMIOLOGY AND CANCER CONTROL
-
批准号:8436432
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
BIOREPOSITORY CENTER
-
批准号:8436441
-
项目类别:
-
资助金额:$13.74万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
DATA AND SAFETY MONITORING
-
批准号:8436456
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
FLOW CYTOMETRY AND CELL SORTING
-
批准号:8436444
-
项目类别:
-
资助金额:$5.56万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
BREAST CANCER
-
批准号:8436433
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS
-
批准号:8436431
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
GENOME TECHNOLOGY CENTER
-
批准号:8436445
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
GENITOURINARY CANCERS
-
批准号:8436437
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
PROTOCOL REVIEW AND MONITORING SYSTEM
-
批准号:8436454
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
CANCER IMMUNOLOGY
-
批准号:8436427
-
项目类别:
-
资助金额:$1.95万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
CLINICAL TRIALS OFFICE
-
批准号:8436453
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2013
-
负责人:William L. Carroll
-
依托单位:
海外基金